T he treatment of young patients (ie, ≤30 years) with end-stage hip disease presents greater challenges than that of general candidates (ie, average age, 65 years) for total hip arthroplasty (THA). Problems with treatment in young patients undergoing THA are reflected in decreased hip function and decreased satisfaction after hip replacement. 1 These limitations are believed to stem from higher activity level and a lack of up-todate prognostic data in these patients. 1 Additionally, young patients undergoing THA are pathologically dissimilar from general patients undergoing this procedure, as evidenced by the unique mixture of comorbidities and mechanistically divergent etiologies of hip disease that are characteristic of the younger group. 1 The authors sought to define activity levels of young patients after THA and to identify predictors of decreased activity. They hypothesized that young THA patients experience postoperative activity levels similar to those of comorbiditymatched peers without hip disease and that the comorbid disease burden of young THA patients may make them as active as or less active than older patients undergoing THA. In the current study, the authors' primary goal was to measure and compare the activity levels of postoperative young THA patients, postoperative general THA patients, and nonarthroplasty patients who were similar to young THA patients in age and comorbidity, but without significant hip disease. Secondary goals included assessment of hip function outcomes, general health outcomes, and comorbid state in these study populations and examination of the effect of patient and clinical characteristics on activity level and hip function outcomes.
Materials and Methods
After approval by the authors' institutional review board was obtained, a query of the operating room information system was run to identify all patients who underwent primary THA (Current Procedural Terminology [CPT] code 27130) performed by 19 adult reconstructive surgeons between December 2000 and June 2010 at the same hospital. The young THA study cohort was defined to include only patients 30 years or younger at the time of surgery (n=113). This age cutoff was frequently used in previous studies when describing young THA patients. [2] [3] [4] [5] [6] [7] Patients undergoing THA for tumor metastasis or for palliative reasons were excluded because it was believed that these patients may represent a different surgical cohort with respect to expectations in hip function (n=3), leaving a final young THA cohort of 110 patients.
Two convenience samples were established for comparison with the primary cohort. First, the authors identified and contacted a general THA patient population, made up of a random selection (ie, via random number generator) of THA patients from the original query who were 31 years or older at the time of surgery. A convenience sample of 158 patients (194 hips) was willing to participate. A 2:1 ratio of general THA patients to young THA patients was sought to ensure wide representation of the older general THA patient population. Second, a nonarthroplasty population, composed of young patients without significant hip disease, but with similar comorbidities as the young THA cohort, was identified through a separate query. At the time of the study, 2 to 15 years had passed since the time of surgery for all young THA patients. Therefore, nonarthroplasty control subjects up to 45 years old were selected. These patients were isolated from the electronic medical record system by searching for individuals who met the age restriction and had 1 of the following 9 diagnoses that were prevalent in the young THA patients: rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthritis, avascular necrosis, thalassemia, sickle cell disease, lymphoma, leukemia, and systemic lupus erythematosus (International .01, and 710.0). Although avascular necrosis is generally a consequence of another disease or injury, it was included to control for the numerous potential causes. Patients with a history of hip procedures or significant hip symptoms were excluded. The authors' goal for this group was to pathologically resemble young THA patients as much as possible, but without hip disease. A random selection of this cohort was contacted, and a convenience sample of 106 patients responded that they were willing to participate.
Outcome Measures
All study participants were asked to complete a packet of validated questionnaires, including the University of California Los Angeles (UCLA) activity score, 8 Hip disability and Osteoarthritis Outcome Score (HOOS), 9 Short Form-12 version 2 (SF-12v2), 10 and Functional Comorbidity Index (FCI). 11 Participants were given the choice of completing this packet by mail, by telephone, or via Internet using a secured website. All THA patients were a minimum of 2 years postoperative. The primary outcome, activity level, was assessed with the UCLA activity score. Activity has been defined with numerous tools in the literature, including the pedometer, Tegner Score, Activity Rating Score, Lower-Extremity Activity Scale, and UCLA activity score. 12, 13 Although the UCLA activity score does not provide information about the frequency, intensity, or duration of activity, it is generally considered the most suitable assessment of physical activity in patients undergoing total joint arthroplasty. 12 This score was chosen for this study because of its reliability, high completion rates, ability to delineate between high-impact and low-impact sports, and popularity within the orthopedic community. 12, 13 Additionally, the UCLA activity score has a strong positive correlation with average steps per day, a known predictor of bearing surface wear. 8, 14 Each patient who had undergone THA was asked to complete 2 UCLA activity questionnaires. The first asked patients to rate their current activity level, and the second asked patients to rate the level of activity that they think THA should provide. Subjects in the nonarthroplasty group were asked only to rate their current activity level.
Secondary outcomes included hipspecific outcomes (HOOS), general health (SF-12v2), and comorbid impairment (FCI). Each of these outcome tools has been tested for validity, reliability, and responsiveness. [8] [9] [10] [11] The HOOS data were gathered for all operative hips in the young THA and general THA groups (ie, left, right, or both [young THA group, bilateral THA, n=29; general THA group, bilateral THA, n=36]). For patients with bilateral THA, average HOOS subscores were used (ie, [left hip subscore+right hip subscore]/2) to maintain the assumption of independence necessary for multivariable linear regression and to avoid giving these patients and their clinical characteristics more weight in the study models. This concern was further addressed in multivariable analyses by inclusion of a dummy variable indicating bilateral hip disease. Patients in the nonarthroplasty group were selected because they had no reported hip disease. Therefore, the HOOS was not administered to these patients. However, SF-12v2 and FCI data were collected for all 3 patient groups.
Additional variables, including age, sex, race (white vs nonwhite), etiology of hip disease, date of surgery, and length of follow-up, were retrieved from the electronic medical record. Etiology of hip disease was collected to better identify possible effects of underlying pathology in THA patients. This variable was categorized as local musculoskeletal disease (eg, primary osteoarthritis, trauma arthritis, developmental dysplasia, Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, achondroplasia), systemic musculoskeletal/connective tissue disease (eg, rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, sarcoidosis, dwarfism), or other systemic disease (ie, not musculoskeletal/connective tissue; eg, drug-induced arthropathy as a result of treatment of other disease, sickle cell disease). Body mass index was not recorded independently because obesity is among the comorbidities included in the FCI. The arthroplasty technique varied widely among the patients in the THA groups and therefore was not included in the data analysis. Details on surgery and the etiology of hip disease were not applicable for the nonarthroplasty group.
Statistical Analyses
The UCLA activity score and HOOS, SF-12v2, and FCI data were treated as quantitative outcomes. Unadjusted differences between patient groups were evaluated with Student's t tests and Pearson's chi-square tests, as appropriate. Tests for differences in activity level were considered significant at P<.05. Tests of secondary outcomes were considered statistically significant at P<.01 to account for multiple comparisons.
Linear regression models were used to adjust for the effects of multiple variables and to identify factors with significant associations with activity level and HOOS subscore. Demographic (ie, sex, race), clinical (ie, current activity level, FCI score), and surgical characteristics (ie, arthroplasty group, etiology of hip disease) were investigated. Multivariable models of activity included a set list of covariates (ie, comorbidity, sex, and race) selected a priori because of their known effects on physical health and activity level. 11 Exploratory analyses, including all covariates believed to possibly affect postoperative hip outcomes, were conducted when constructing the adjusted HOOS subscore models. Therefore, interaction terms between the THA groups and all noted demographic, clinical, and surgical characteristic covariates were included in initial multivariable HOOS regression models. Final model covariates were chosen through forward selection or backward elimination stepwise linear regression, based on which approach provided the greater accountancy of variation from the mean (ie, R 2 ). All analyses were completed with JMP v7.0 (SAS Institute Inc, Cary, North Carolina).
Sensitivity analysis was conducted because of complete dependence of all outcomes on patient-reported surveys and the difficulty in obtaining completed surveys from the young THA group. A propensity score was developed to model subjects' likelihood of survey completion, given demographic characteristics (ie, age at surgery, age at follow-up, race, occupation, distance from the hospital [miles], state of residence [Ohio vs not Ohio], and median income for zip code) and patient characteristics (ie, etiology of hip disease, time spent in the hospital system [number of years between the first and last visits]). Activity differences between groups were evaluated with and without propensity score adjustment via weighting according to the inverse likelihood of survey completion. This was done to allow equal representation of patient subgroups.
results
Of the 110 patients in the young THA group, 6 were deceased at the time of follow-up contact. Of the remaining 104 living patients (38 bilateral cases; 142 hips), follow-up was attained for 70 (67%) patients (99 of 142 hips; 70%) (lost to follow-up or refused to participate, n=32; resident of a foreign country, n=1; no contact or clinical information in any institution or Internet database, n=1). Mean follow-up (ie, time between THA surgery and questionnaire response) was 6.6 years (range, 2.1-14.9). At the time of questionnaire follow-up, the mean age of the study cohort was 30.9 years (range, 19.4-43.1).
Demographic and clinical information for all patient groups is shown in Table 1 . Women were more prevalent than men in each group, and this difference was greater in the nonarthroplasty group. The 3 groups did not differ significantly in racial composition (P=.11). According to the study design, patients in the young THA group were younger than those in the general THA group and similar in age to those in the nonarthroplasty group. The young THA group showed considerably more variation in etiology of hip disease than the general THA group (P<.001). Etiology of hip disease in the young THA group included local musculoskeletal, systemic musculoskeletal/connective, and other systemic causes at a ratio of approximately 3:2:1. Etiology of hip disease in the young THA group was most commonly inflammatory arthritis (n=16), trauma (n=11), Legg-Calvé-Perthes disease (n=11), developmental dysplasia (n=9), drug use for other disease (n=7), and systemic lupus erythematosus (n=5). Conversely, the etiology of hip disease in the general THA group was almost exclusively local musculoskeletal (91%) because an overwhelming majority of these patients had a diagnosis of primary osteoarthritis (91%). The crude differences in activity level, hip-specific outcomes, general health, and comorbid state by patient group are shown in Table 2 . All 3 study groups had similar mean postoperative activity at follow-up (young THA group, 6.5; general THA group, 6.4; nonarthroplasty group, 6.6; P=.62). Despite very similar current activity levels, patients in the young THA group expected greater activity levels than did those in the general THA group (7.7 vs 7.1, respectively; P=.02). Additionally, those in the young THA group expected that THA would provide activity levels considerably higher than those of the young, comorbidity-matched patients in the nonarthroplasty group, who had no significant hip disease.
The HOOS results showed that the young THA group had significantly more hip symptoms (P=.003) and a lower hip-related quality of life (P<.001) than the general THA group. Analysis of SF-12v2 data showed that postoperative physical health composite scores were similar between patient groups (P=.31). Mental health composite scores differed significantly between groups, with the general THA group having a slightly higher mean mental health score than the other 2 groups (P<.001). Despite higher mental health scores, the general THA group had significantly poorer comorbid states than the other patient groups (P<.001).
The interactions of activity with age, patient group, comorbidity, etiology of hip disease, sex, and race were studied with univariable and multivariable analyses. The Figure shows the crude relationships of postoperative activity with comorbidity (P<.001) and age (P=.23) in patients who underwent THA. Whereas the linear association between comorbidity and activity was readily appreciable, an interaction between age and activity was neither clinically nor statistically significant. Results of multivariable analyses modeling activity with respect to patient and clinical characteristics are shown in Table 3 . No evident association was found between arthroplasty group and current activity level, matching conclusions shown in Table 2 (P=.47). Activity was significantly associated with FCI and sex (P<.001). After adjustment, every 1-point increase in the FCI resulted in an average decrease of 0.34 points in current activity level. Thus, as the comorbid state worsened, activity levels worsened. Furthermore, on average, men had an activity score 1.28 points higher than women and hence better activity levels. No significant relationships were found between activity and etiology of hip disease (P=.54) or between activity and race (P=.06). Etiology of hip disease was not included in the multivariable analyses because patients in the nonarthroplasty group were presumably free of hip disease. Similar results were obtained when participant responses were weighted according to propensity for survey completion (data not shown). Table 4 shows the unadjusted associations of HOOS subscores with arthroplasty group, comorbidity, and etiology of hip disease. These analyses confirmed the authors' findings that patients in the general THA group appear to have significantly fewer symptoms and better hip-related quality of life than the patients in the young THA group ( Table  2) . No significant associations were seen between etiology of hip disease and any HOOS subcategory (range, P=.04 to P=.48). Table 5 shows the multivariable linear regression models of each HOOS subcategory. The final HOOS subscore models consisted of 2 to 4 covariates each after the variable selection process was implemented. Patients in the general THA group had significantly better hip-related quality of life than those in the young THA group; all other outcomes were similar in the 2 patient groups. As in the unadjusted analyses, significant worsening of pain and activities of daily living occurred with worsening comorbid disease (P<.001). White patients reported significantly improved pain, activities of daily living, and hip-related quality of life compared with nonwhites (P<.001, P<.001, and P=.009, respectively). No variables met the inclusion criteria for the sports and recreation function model. 2, 3, 16, 17 Midterm and long-term survival rates of 82% to 95% were reported in hips undergoing implantation after the 1990s in young patients. [3] [4] [5] [6] Additionally, reported clinical outcomes 
preoperatively).
Postoperative activity is a critically important, yet complicated factor for both surgeon and patient. Although activity level is positively associated with postoperative satisfaction, it may affect prosthesis failure as well. 18 As the average patient undergoing THA is becoming younger, 19 the role of activity as a marker of quality of life is becoming increasingly apparent. Lieberman et al 20 noted the importance of postoperative activity in terms of patient satisfaction, despite a potentially conflicting physician assessment. Cardiovascular and other health benefits of exercise also likely play a substantial role in postoperative quality of life. [21] [22] [23] Conversely, highly active postoperative lifestyles predispose patients to bearing surface wear, 14, 24 mechanical failure, 25 and the need for revision THA. 18, 26 In practice, after weighing the benefits and detriments, greater emphasis is being placed on low-impact activities (eg, walking, bicycling, swimming, golf) postoperatively. In a 2007 survey of members of the American Association of Hip and Knee Surgeons, 95% of physicians placed no restrictions on lowimpact activities. However, high-impact activities, such as jogging and difficult skiing, were considered deleterious to hip implants and were discouraged by 71% and 83% of respondents, respectively. 27 An implicit fear concerning THA in very young patients is that this group will ignore restrictions on high-impact activities and doom their implanted prostheses. The current results suggest that high postoperative activity levels should not be assumed in young patients, a finding likely related to the unique pathologic features of very young THA patients compared with the general THA population. 1 Hip disease in patients 30 years or younger is predominantly caused by osteonecrosis, juvenile rheumatoid arthritis, sequelae of developmental dysplasia, osteoporo- sis, posttraumatic arthritis, and pseudorheumatoid chondrodysplasia. 1, 3 Although all of these diagnoses pose obstacles to THA in young patients, osteoarthritis secondary to developmental dysplasia presents additional surgical complexity because anatomic abnormalities may further impair postoperative activity levels and outcomes. 28 Additional studies have found older age to significantly predict lower activity after THA. [29] [30] [31] The authors do not consider the results of the current study as necessarily conflicting because of the different age ranges observed, the heterogeneous patient populations, and alternate definitions of activity. Singh and Lewallen 29, 30 noted increased likelihood of activity limitation among older patients after THA (ie, 71-80 years, >80 years). Kinkel et al 31 found that the relationship between postoperative daily walking cycles and age exhibited a parabolic shape, peaking in the sixth decade (50-59 years) and then sharply declining in subsequent decades. Although the authors found no evidence of a linear relationship between activity and age, there was an age gap in the current study's data. Patients who were 30 to 45 years old at the time of surgery were underrepresented relative to other age groups because most patients who undergo arthroplasty are 60 years or older. Therefore, given the study findings, activity is likely to exhibit a nonlinear relationship with age or may be linear over smaller intervals.
A notable limitation of this study was the inability to directly assess the effectiveness of THA in improving function because of a lack of preoperative outcome data. For young THA patients, this limitation was at least partially mitigated by the inclusion of subjects similar in age and comorbidity but without hip disease. Relative improvements in function cannot be evaluated with these data; however, the congruence in activity exhibited by the young THA group and the nonarthroplasty group, made up of similar peers without hip disease or surgery, suggests that (1) the previously diseased hips of young THA patients do not significantly hinder postoperative activity and (2) most patients 30 years or younger can be expected to become as active as their comorbidities allow.
The disparity in FCI scores across groups, despite similar overall physical health and activity levels, suggests differential age-related effects of disease on physical health and activity. For example, on average, depression and anxiety after THA may be more debilitating in a 20-year-old patient than in a 63-year-old patient. Alternatively, many comorbidities that are common in young THA patients, although contributing significantly to physical health, may not be reflected in FCI scores (ie, sickle cell disease), suggesting a need for reevaluation of diagnoses that significantly affect physical health, particularly in very young patients.
In this study, the young THA group and the general THA group were pathologically different, as shown by significantly different causes of hip disease and FCI scores. Interestingly, the etiology of hip disease did not significantly predict activity or hip-specific HOOS outcomes in the young THA group or the general THA group. A caveat to this finding is that hip disease was ultimately categorized into very broad groups. It is possible that hip disease, when characterized at a more granular level (eg, juvenile rheumatoid arthritis, traumatic arthritis, developmental dysplasia, avascular necrosis secondary to leukemia treatment), does predict activity and functional outcomes. However, the sample size of the current study does not support such analyses.
In addition to the absence of preoperative outcome data, this study had other notable limitations. The outcomes from this study were derived from self-reported data. Although patient-reported data have been shown to be among the most important outcomes in orthopedic patients, data collection was limited by the patients' willingness and ability to follow up. Consequently, selection bias was a potential limitation. The authors attempted to mitigate the effect of this potential bias by performing additional analyses to adjust for the propensity of survey completion. Conclusions remained unchanged and thus were not presented.
conclusion
On average, postoperatively, patients in the young THA group engaged in regular moderate activity peppered with intermittent low-impact events, such as bicycling (based on UCLA activity scores). This study showed that THA in young patients is effective in imparting function to otherwise dysfunctional joints and that these patients are just as active as their peers with similar diseases, but healthy hips. Furthermore, patients in the young THA and general THA groups had similar postoperative function, as shown by nonsignificant differences in activity, most hip-specific outcomes, and general physical health.
Given these findings, the potential risk of a dangerously active lifestyle seems minimal in young patients undergoing THA. Interestingly, despite the equivalence in achieved activity, young patients undergoing THA tend to expect higher postoperative activity and report decreased quality of life compared with older patients undergoing THA. Given the relationship between expectations of surgery and postoperative satisfaction, this study highlighted the plausible management of patient satisfaction in preoperative counseling, namely, a well-balanced discussion of the probable improvements in activity within the confines of the physical limitations imposed by comorbid disease.
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